Medical University of Bialystok. Publications.
  • Updated 18.11.2020 by Administrator Zakładu

    Publications

    Publications of the Department’s Staff 2015-2020:

    1. Lleó A, Cavedo E, Parnetti L, Vanderstichele H, Herukka SK, Andreasen N, Ghidoni R, Lewczuk P, Jeromin A, Tsolaki M, Mroczko B, Visser PJ, Santana I, Svenningsson P, Blennow K, Aarsland D, Molinuevo JL, Zetterberg H, Mollenhauer B. Cerebrospinal fluid biomarkers in clinical trials for Alzheimer’s and Parkinson’s disease. Nat Rev Neurol. 2015;11(1):41-55. MNISW: (50.00); IF: 18.418; Medline.
    2. Mroczko B, Groblewska M, Zboch M, Muszyński P, Zajkowska A, Borawska R, Szmitkowski M, Kornhuber J, Lewczuk P. Evaluation of visinin-like protein 1 concentrations in the cerebrospinal fluid of patients with mild cognitive impairment as a dynamic biomarker of Alzheimer’s disease. J Alzheimers Dis. 2015;43(3):1031-1037. MNISW (35.000); IF: 3.920; Medline.
    3.  Lewczuk P, Mroczko B, Fagan A, Kornhuber J. Biomarkers of Alzheimer's disease and mild cognitive impairment: A current perspective. Adv. Med. Sci. 2015;60:76-82. MNISW: (15.00); IF: 1.211; Medline.
    4. Wereszczyńska-Siemiątkowska U, Siemiątkowski A, Świdnicka-Siergiejko A, Mroczko B, Dąbrowski A. The imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in acute pancreatitis. Zeitschrift für Gastroenterologie 2015;53:199-204. MNISW (15.000); IF: 1.357; Medline.
    5.  Groblewska M, Muszyński P, Wojtulewska-Supron A, Kulczyńska-Przybik A, Mroczko B. The Role of Visinin-Like Protein-1 in the pathophysiology of Alzheimer’s Disease. J Alzheimers Dis. 2015;47(1):17-32. MNISW (35.000); IF: 3.920; Medline
    6.  Siemiątkowski A, Wereszczyńska-Siemiątkowska U, Mroczko B, Galar M, Maziewski T. Circulating endothelial mediators in human pancreatitis-associated lung injury. Eur J Gastroenterol Hepatol. 2015;27(6):728-734. MNISW (20.000); IF 2.093; Medline.
    7. Jansen WJ, Ossenkoppele R, …, Mroczko B, …, Zboch M, Zetterberg H. Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia. A Meta-analysis. JAMA 2015;313(19):1924-1938. MNISW (50.000); IF: 37.684; Medline.
    8.  Łukaszewicz-Zając M, Mroczko B, Szmitkowski M. Chemokines and their receptors in esophageal cancer-the systematic review and future perspectives. Tumour Biol. 2015;36(8):5707-5714, MNISW (30.000); IF: 2.926; Medline.
    9. Wereszczyńska-Siemiątkowska U, Świdnicka-Siergiejko A, Siemiątkowski A, Bondyra Z, Wasielica-Berger J, Mroczko B, Janica J, Dąbrowski A. Endothelin 1 and transforming growth factor-β1 correlate with liver function and portal pressure in cirrhotic patients. Cytokine 2015;76(2):144-151. MNISW (25.000); IF: 2.940; Medline.
    10.  Andreasson U, Perret-Liaudet A, van Waalwijk van Doorn LJ, Blennow K, Chiasserini D, Engelborghs S, Fladby T, Genc S, Kruse N, Kuiperij HB, Kulic L, Lewczuk P, Mollenhauer B, Mroczko B, Parnetti L, Vanmechelen E, Verbeek MM, Winblad B, Zetterberg H, Koel-Simmelink M, Teunissen CE. A Practical Guide to Immunoassay Method Validation. Front Neurol. 2015;6:179:1-8. MNISW (0.000); IF: 3.184
    11.  Zajkowska J, Lelental N, Kulakowska A, Mroczko B, Pancewicz S, Bucki R, Kornhuber J, Lewczuk P. Application of multiplexing technology to the analysis of the intrathecally released immunoglobulins against B. burgdorferi antigens in neuroborreliosis. Immunol Lett. 2015;168(1):58-63. MNISW (20.000); IF: 2.483; Medline
    12.  Mroczko B, Kulczyńska-Przybik A, Łukaszewicz-Zając M, Kornhuber J, Lewczuk P. The usefulness of visinin-like protein 1 as a potential biomarker of Alzheimer’s disease. Drugs of the future 2015;40(11):751-756. MNISW (15.000); IF: 0.103; Medline
    13. Sieśkiewicz A, Groblewska M, Łysoń T, Piszczatowski B, Turek G, Rutkowski R, Mroczko B, Rogowski M, Mariak Z. Neurobiochemical markers of brain ischemia in patients subjected to endoscopic skull base surgery under controlled hypotension.
      J Neurosurg Sci. 2015;60(3):313-319. MNISW: (20.000); IF:1.651; Medline.
    14.  Olszewska E, Matulka M, Mroczko B, Pryczynicz A, Kemona A, Szmitkowski M, Mierzwiński J, Pietrewicz T. Diagnostic value of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinases 1 in cholesteatoma. Histol Histopathol. 2016;31(3):307-315. MNISW (25.000); IF: 2.025; Medline
    15.  Dziedzic T, Pera J, Klimkowicz-Mrowiec A, Mroczko B, Słowik A. Biochemical and Radiological Markers of Alzheimer’s Disease Progression. J Alzheimers Dis. 2016;50(3):623-644. MNISW (30.000); IF: 3.731; Medline
    16.  Łukaszewicz-Zając M, Mroczko B, Kozłowski M, Szmitkowski M. The serum concentrations of chemokine CXCL12 and its specific receptor CXCR4 in patients with esophageal cancer. Disease Markers 2016; Article ID 7963895, 7 pp.; MNISW (25.000);
      IF: 2.348; Medline
    17.  Lelental N, Brandner S, …, Mroczko B, …, Kornhuber J, Lewczuk P. Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics. J Alzheimers Dis. 2016; 52: 51-64. MNISW (30.000); IF: 3.731; Medline.
    18.  Mroczko B, Kulczyńska-Przybik A, Mroczko P. Wykluczenie społeczne chorych na chorobę Alzheimera. Wybrane prawne, kryminologiczne i medyczne aspekty wykluczenia społecznego. Temida, Białystok 2016; 279-297. MNISW (4.000).
    19.  Łukaszewicz-Zając M, Szmitkowski M, Litman-Zawadzka A, Mroczko B. Matrix metalloproteinases and their tissue inhibitors in comparison to other inflammatory proteins in gastric cancer (GC). Cancer Invest. 2016; 34: 305-312. MNISW (20.000); IF: 2.007; Medline
    20.  Łukaszewicz-Zając M, Kulczyńska-Przybik A, Muszyński P, Kozłowski M, Szmitkowski M, Mroczko B. Serum concentrations of receptor for interleukin 8 in patients with esophageal cancer. Pol Arch Med Wewn 2016; 126: 854-861. MNISW (30.000); IF: 2.191
    21. ­ Łukaszewicz-Zając M, Mroczko B, Kozłowski M, Szmitkowski M. Stem cell factor (SCF) in the serum of patients with esophageal cancer (EC) in relation to its histological types. Archives of Medical Science 2017; 13: 6: 1357-1364. MNISW (30.000); IF: 2.344
    22. Lewczuk P, Lelental N, Lachmann I, Holzer M, Flach K, Brandner S, Engelborghs S, Teunissen CE, Zetterberg H, Molinuevo JL, Mroczko B, Blennow K, Popp J, Parnetti L, Chiasserini D, Perret-Liaudet A, Spitzer P, Maler JM, Kornhuber J. Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization. J Alzheimers Dis. 2017; 55: 159-170. MNISW (35.000); IF: 3.476
    23.  Simonsen AH, Herukka SK, Andreasen N, Baldeiras I, Bjerke M, Blennow K, Engelborghs S, Frisoni GB, Gabryelewicz T, Galluzzi S, Handels R, Kramberger M, Kulczyńska-Przybik A, Molinuevo JL, Mroczko B, Nordberg A, Oliveira CR, Otto M, Rinne JO, Rot U, Saka E, Soininen H, Struyfs H, Suardi S, Visser PJ, Winblad B, Zetterberg H, Waldemar G. Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia. Alzheimers Dement. 2017; 13: 274-284. MNISW (50.000); IF: 12.740
    24.  Herukka SK, Simonsen AH, Andreasen N, Baldeiras I, Bjerke M, Blennow K, Engelborghs S, Frisoni GB, Gabryelewicz T, Galluzzi S, Handels R, Kramberger M, Kulczyńska-Przybik A, Molinuevo JL, Mroczko B, Nordberg A, Oliveira CR, Otto M, Rinne JO, Rot U, Saka E, Soininen H, Struyfs H, Suardi S, Visser PJ, Winblad B, Zetterberg H, Waldemar G. Recommendations for CSF AD biomarkers in the diagnostic evaluation of MCI. Alzheimers Dement. 2017;13:285-295. MNISW (50.000); IF: 12.740
    25.  Kuć P, Charkiewicz R, Klasa-Mazurkiewicz D, Milczek T, Mroczko B, Nikliński J, Laudański P. Profiling of selected angiogenesis-related genes in serous ovarian cancer patients. Adv Med Sci. 2017; 62: 116-120. MNISW (15.000); IF: 2.064
    26.  Muszyński P, Groblewska M, Kulczyńska-Przybik A, Kułakowska A, Mroczko B. YKL-40 as a potential biomarker and a possible target in therapeutic strategies of Alzheimer's disease. Current Neuropharmacology 2017; 15: 906-917. MNISW (35.000); IF: 4.068
    27.  Muszyński P, Kulczyńska-Przybik A, Borawska R, Litman-Zawadzka A, Słowik A, Klimkowicz-Mrowiec A, Pera J, Dziedzic T, Mroczko B. The relationship between markers of inflammation and degeneration in the central nervous system and the blood-brain barrier impairment in Alzheimer’s disease. J Alzheimers Dis. 2017; 59: 903-912. MNISW (35.000); IF: 3.476
    28.  Niklinski J, Kretowski A, …, Mroczko B, Malyszko J, Manegold C, Pilz L, Allgayer H, Abba ML, Juhl H, Koch F; MOBIT Study Group. Systematic biobanking, novel imaging techniques, and advanced molecular analysis for precise tumor diagnosis and therapy: The Polish MOBIT project. Adv Med Sci. 2017; 62: 405-413. MNISW (15.000); IF: 2.064
    29.  Jedynak M, Siemiatkowski A, Mroczko B, Groblewska M, Milewski R, Szmitkowski M. Soluble TREM-1 Serum Level can Early Predict Mortality of Patients with Sepsis, Severe Sepsis and Septic Shock. Arch Immunol Ther Exp. 2018; 66, 4: 299-306 MNISW (25.000); IF: 2.878
    30.  Jansen W, Ossenkoppele R, Tijms B, Fagan A, …, Mroczko B, …,Verhey F, Jelle Visser P. Cognitive correlates of cerebral amyloid pathology in persons without dementia. JAMA Psychiatry. 2018; 75: 84-95. MNISW (50.000); IF: 15.916
    31.  Mroczko B, Groblewska M, Litman-Zawadzka A, Kornhuber J, Lewczuk P. Amyloid beta oligomers (AbetaOs) in Alzheimer’s disease. Journal of Neural Transmission. 2018; 125, 2: 177-191 MNISW (25.000); IF: 2.903.
    32.  Mattsson N, Groot C,  Jansen WJ, …, Mroczko B, …, Ossenkoppele R. Prevalence of the Apolipoprotein E ε4 allele in amyloid-β positive subjects across the spectrum of Alzheimer's disease. Alzheimers Dement. 2018; 14, 7: 913-924 MNISW (50.000); IF: 14.423
    33.  Łukaszewicz-Zając M, Gryko M, Mroczko B. The role of selected chemokines and their specific receptors in pancreatic cancer. Int J Biol Markers. 2018; 33: 141-147. MNISW (20.000); IF: 1.767
    34.  Kułakowska A, Tarasiuk J, Kapica-Topczewska K, Chorąży M, Pogorzelski R, Kulczyńska-Przybik A, Mroczko B, Bucki R. Pathophysiological implications of actin free Gc-globulin concentration changes in blood plasma and cerebrospinal fluid collected from patients with Alzheimer disease and other neurological disorders. Adv Clin Exp Med. 2018; 27, 8: 1075-1080 MNISW (15.000); IF: 1.227
    35.  Mroczko B, Groblewska M, Litman-Zawadzka A, Kornhuber J, Lewczuk P. Cellular receptors of Amyloid β Oligomers (ABOs) in Alzheimer's disease. International Journal of Molecular Sciences 2018; 19, 7: E1884 19 pp. MNISW (30.000); IF: 4.183
    36.  Lewczuk P, Gaignaux A, Kofanova O, Ermann N, Betsou F, Brandner S, Mroczko B, Blennow K, Strapagiel D, Paciotti S, Vogelgsang, Roehrl MH, Mendoza S, Kornhuber J, Teunissen Ch. Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease. Alzherimer’s Research & Therapy. 2018; 10, 1, Article no. 87, 9 pp.  MNISW (40.000); IF: 6.142 (2-letni IF).
    37.  Litman-Zawadzka A, Łukaszewicz-Zając M, Gryko M, Kulczyńska-Przybik A, Mroczko B. Serum chemokine CXCL8 as a better biomarker for diagnosis and prediction of pancreatic cancer than its specific receptor CXCR2, C-reactive protein, and classic tumor markers CA 19-9 and CEA. PAMW. 2018; 128, 9: 524-531 MNISW (30.000); IF: 2.882
    38.  Piskór BM [SD], Lubowicka E [SD], Ławicki S, Mroczko B, Przylipiak A. Wybrane zabiegi z zakresu kosmetologii i medycyny estetycznej u chorych na łuszczycę. Polish Journal of Cosmetology. 2018; 21, 3: 229-234. MNISW (7.000)
    39. Tarasiuk J, Kapica-Topczewska K, Szczepański M, Kochanowicz J, Mroczko B, Kułakowska A. Korelacje pomiędzy stężeniami biomarkerów w płynie mózgowo-rdzeniowym a nasileniem zaburzeń funkcji poznawczych w chorobie Alzheimera. Pielęgniarstwo Neurologiczne i Neurochemiczne. 2018; 7, 4: 150-154. MNISW (6.000)
    40.  Świdnicka-Siergiejko A, Wereszczyńska-Siemiątkowska U, Siemiątkowski A, Wasielica-Berger J, Janica J, Mroczko B, Dąbrowski A. The imbalance of peripherial interleukin-18 and transforming growth factor-β1 levels in patients with cirrhosis and esophageal varices. Cytokine. 2019: 113: 440-445. MNISW (100.000); IF: 3.078.
    41. Kazimierczyk E, Eljaszewicz A, Zembko P, Tarasiuk E, Rusak M, Kulczyńska-Przybik A, Łukaszewicz-Zając M, Kamiński K, Mroczko B, Szmitkowski M, Dąbrowska M, Sobkowicz B, Moniuszko M, Tycińska A. The relationships among monocyte subsets, miRNAs and inflammatory cytokines in patients with acute myocardial infraction. Pharmacological Reports. 2019: 71, 1: 73-81. MNISW (70.000); IF: 2.761.
    42. Baldeiras I, Santana I, Leitao MJ, Vieira D, Duro D, Mroczko B, Kornhuber J, Lewczuk P. Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer's disease. Alzheimer's Research & Therapy. 2019: 11, 1, Article number: 2: 11pp. MNISW (140.000); IF: 6.142.
    43.  Łukaszewicz-Zając M, Gryko M, Pączek S, Szmitkowski M, Kędra B, Mroczko B. Matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor 2 (TIMP-2) in pancreatic cancer (PC). Oncotarget. 2019: 10, 3: 395-403. MNISW (100.000).
    44.  Czupryna P, Mroczko B, Pancewicz AS, Muszyński P, Grygorczuk, Dunaj J, Borawski K, Róg-Makal M, Świerzbińska R, Zajkowska J, Kondrusik M, Moniuszko-Malinowska A. Assessment of the Tau protein concentration in patients with tick-borne encephalitis. European Journal of Clinical Microbiology & Infectious Diseases. 2019: 38, 3: 479-483. MNISW (100.000); IF: 2.591.
    45.  Litman-Zawadzka A, Łukaszewicz-Zając M, Mroczko B. Novel potential biomarkers for pencreatic cancer – A systematic review. Advances in Medical Sciences. 2019 ; 64, 2: 252-257. MNiSW (100.000); IF: 2.080.
    46.  Łukaszewicz-Zając M, Pączek S, Muszyński P, Kozłowski M, Mroczko B. Comparison between clinical significance of serum CXCL8 and classical tumor markers in oesophageal cancer (OC) patients. Clinical and Experimental Medicine. 2019; 19, 2: 191-199. MNiSW (70.000); IF: 2.642.
    47.  Tarasiuk J, Kapica-Topczewska K, Chorąży M, Borowik-Zaręba A, Mroczko B, Kochanowicz J, Kułakowska A. The comparisons of blood plasma and cerebrospinal fluid S100B protein concentrations in patients with Alzheimer’s disease, amyotrophic lateral sclerosis, and multiple sclerosis. Progress in Health Sciences. 2019; 53: 9, 1: 22-27. MNiSW (5.000).
    48.  Kozłowski T, Rydzewska-Rosołowska A, Myśliwiec J, Choromańska B, Wojskowicz P, Dadan J, Łukaszewicz-Zając M, Mroczko B, Myśliwiec P. Impact of laparoscopic adrenalectomy on renal function. Results of prospective randomized clinical trial. Endokrynologia Polska. 2019; 70, 10 pp. MNiSW (40.000); IF: 1.521.
    49.  Jedynak M, Siemiątkowski A, Milewski R, Mroczko B, Szmitkowski M. Diagnostic effectiveness of soluble triggering receptor expressed on myeloid cells-1in sepsis, severe sepsis and septic shock. Archives of Medical Science. 2019; 15, 3: 713-721.  MNiSW (70.000); IF: 2.380.
    50.  Charkiewicz AE, Omeljaniuk W, Orywal K, Czygier M, Szmitkowski M, Mroczko B, Maślach D, Szpak A. Concentration of selected elements and antioxidative potential in a group of males working in the metal industry: elements and antioxidative potential in men. American Journal of Men’s Health. 2019; pp10. MNiSW (70.000); IF: 1.409.
    51.  Pieczyńska J, Płaczkowska S, Sozański R, Orywal K, Mroczko B, Grajeta H. Is maternal dietary selenium intake related to antioxidants status and the occurrence of pregnancy complications? Journal of Trace Elements in Medicine and Biology. 2019; 54: 110-117. MNiSW (100.000); IF: 2.895.
    52.  Łucejko M, Tomasiewicz K, Olczak A, Tudrujek-Zdunek M, Halota W, Jelski W, Donica M, Krintus M, Mroczko B, Flisiak R. Hepatitis C virus core antigen as a possible alternative for evaluation of treatment effectiveness after treatment with direct-acting antivirals. British journal of biochemical science. 2019;76,4:190-194. MNiSW (40.000); IF: 2.365.
    53.  Matulka M, Konopko A, Mroczko B, Pryczynicz A, Kemona A, Groblewska M, Sieśkiewicz A, Olszewska E. Expression and concentration of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinases 1 in laryngeal squamous cell carcinoma. Disease Markers. 2019; 9pp. MNiSW (70.000); IF: 2.761.
    54.  Mirońska A, Łukaszewicz-Zając M, Mroczko B. Clinical Significance of Selected Chemokines in Thyroid Cancer. Anticancer research. 2019; 39, 6: 2715-2720. MNiSW (70.000); IF: 1.935.
    55.  Jelski W, Mroczko B. Biochemical diagnostics of pancreatic cancer – present and future. Clinica Chimica Acta. 2019; 498: 47-51. MNiSW (100.000); IF: 2.735.
    56.  Mroczko B, Groblewska M, Litman-Zawadzka A. The role of protein misfolding and Tau oligomers (TauOs) in Alzheimer’s Disease (AD). IJMS. 2019; 20,19, Article number 4661, 26 pp. MNiSW (140.000), IF: 4.183.
    57.  Tarasiuk J, Kapica-Topczewska K, Chorąży M, Mroczko B, Kochanowicz J, Kułakowska A. Is vitamin D deficiency a reliable risk factor for multiple sclerosis development? Neurologia i Neurochirurgia Polska. 2019 : 53, 2 pp.  MNiSW (40.000); IF: 1.006.
    58. Gudowska-Sawczuk M, Mroczko B. Free light chains as a novel diagnostic biomarker of immune system abnormalities in multiple sclerosis and HIV infection. BioMed Research International. 2019. Article ID 8382132, 7pp. MNiSW (70.000); IF: 2.197.
    59. Dąbrowska Z, Dąbrowska E, Onopiuk B, Onopiuk P, Orywal K, Mroczko B, Pietruska M. The protective impact of black chokeberry fruit extract (Aronia melanocarpa L.) on the oxidoreductive system of the parotid gland of rats exposed to cadmium. Oxidative Medicine and Cellular Longevity. 2019, Article ID 3403264, 11 pp. MNiSW (100.000); IF: 4.868.
    60. Rabbito A, Dulewicz M, Kulczyńska-Przybik A, Mroczko B. Biochemical Markers in Alzheimer's Disease. Int J Mol Sci. 2020 Mar 14;21(6). pii: E1989. DOI:10.3390/ijms21061989 MNiSW (140.000); IF: 4.183.
    61. Łukaszewicz-Zając M, Pączek S, Mroczko B. The significance of chemokine CXCL-8 in esophageal carcinoma. Arch Med Sci. 2020 Feb 4;16(2):475-480. DOI:10.5114/aoms.2017.71933 MNiSW (70.000); IF: 2.380.
    62. Pączek S, Łukaszewicz-Zając M, Gryko M, Mroczko P, Kulczyńska-Przybik A, Mroczko B. CXCL-8 in Preoperative Colorectal Cancer Patients: Significance for Diagnosis and Cancer Progression. Int J Mol Sci. 2020 Mar 17;21(6). pii: E2040. DOI:10.3390/ijms21062040 MNiSW (140.000); IF: 4.183.
    63. Pączek S, Łukaszewicz-Zając M, Mroczko B. Chemokines-What Is Their Role in Colorectal Cancer? Cancer Control. 2020; 27(1): 1073274820903384. DOI:10.1177/1073274820903384. MNiSW (100.000); IF: 1.990.
    64. Jelski W, Piechota J, Orywal K, Mroczko B. The alterations in alcohol dehydrogenase activity in the sera of women with intrahepatic cholestasis of pregnancy. Anticancer Research. 2020 : 40, 4, s. 1997-2001. MNiSW (70.000) IF: 1.935.
    65. Gudowska-Sawczuk M, Tarasiuk J, Kułakowska A, Kochanowicz J, Mroczko B. Kappa free light chains and IgG combined in a novel algorithm for the detection of multiple sclerosis. Brain Sciences. 2020 : 10, 6, 12 pp. MNiSW (100.000) IF: 2.786.
    66. Zajkowska M, Mroczko B. Eotaxins and their receptor in colorectal cancer - a literature review. Cancers. 2020 : 12, 6, 16 pp. MNiSW (140.000) IF: 6.162.
    67. Wasilewski T, Łukaszewicz-Zając M, Wasilewska J, Mroczko B. Biochemistry of infertility. Clinica Chimica Acta. 2020 : 508, s. 185-190. MNiSW (100.000) IF: 2.735.
    68. Gudowska-Sawczuk M, Mroczko B. Chemokine ligand 13 (CXCL13) in neuroborreliosis and neurosyphilis as selected spirochetal neurological diseases: a review of its diagnostic significance. IJMS. 2020 : 21, 8, 14 pp. MNiSW (140.000) IF: 4.183
    69. Groblewska M, Litman-Zawadzka A, Mroczko B. The role of selected chemokines and their receptors in the development of gliomas. IJMS. 2020 : 21, 52 pp. MNiSW (140.000) IF: 4.183
    70. Jelski W, Mroczko B. Biochemical markers of colorectal cancer - present and future. Cancer Management and Research. 2020 : 12, s. 4789-4797. MNiSW (140.000) IF: 2.886
    71. Orywal K, Jelski W, Kozłowski MD, Mroczko B. Activity of alcohol dehydrogenase and aldehyde dehydrogenase in lung cancer cells. Anticancer Research. 2020 : 40, 7, s. 3857-3863. MNiSW (70.000) IF: 1.994
    72. Litman-Zawadzka A, Łukaszewicz-Zając M, Gryko M, Kulczyńska-Przybik A, Kędra B, Mroczko B. Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer. IJMS. 2020;21(17):E6193. MNiSW (140.000) IF: 4.556
    73. Dulewicz M, Kulczyńska-Przybik A, Mroczko B. Neurogranin and VILIP-1 as molecular indicators of neurodegeneration in Alzheimer's disease: A systematic review and meta-analysis. IJMS. 2020 : 21, 21, 19 pp, Article ID 8335. MNiSW (140.000) IF: 4.556
    74. Gudowska-Sawczuk M, Kudelski J, Mroczko B. The role of chemokine receptor CXCR3 and its ligands in renal cell carcinoma. IJMS. 2020 : 21, 22, 11 pp, Article ID 858 MNiSW (140.000) IF: 4.556
    75. Pawluczuk E, Łukaszewicz-Zając M, Mroczko B. The role of chemokines in the development of gastric cancer - diagnostic and therapeutic implications. IJMS. 2020 : 21, 22, 14 pp, Article ID 8456. MNiSW (140.000) IF: 4.556
    76. Gruszewska E, Cylwik B, Gińdzieńska-Sieśkiewicz E, Kowal-Bielecka O, Mroczko B, Chrostek L. Diagnostic power of galectin-3 in rheumatic diseases. Journal of Clinical Medicine. 2020 : 9, 10, 9 pp, Article ID 3312. MNiSW: (140.000) IF: 3.303
In order to provide services at the highest level, we use cookies. Using our website means that they will be stored on your device. You can change your browser settings at any time.
See cookies policy.
I accept
Zamknij